Katakam and co-workers have not shown SSRIs to be harmful and ineffective and should stop claiming that they have.
- Published in:
- Acta Neuropsychiatrica, 2018, v. 30, n. 5, p. 266, doi. 10.1017/neu.2018.15
- By:
- Publication type:
- Article
Works matching IS 09242708 AND DT 2018 AND VI 30 AND IP 5
Results: 6
1
2
Great boast, small roast on effects of selective serotonin reuptake inhibitors: response to a critique of our systematic review.
- Published in:
- Acta Neuropsychiatrica, 2018, v. 30, n. 5, p. 251, doi. 10.1017/neu.2017.38
- By:
- Publication type:
- Article
3
Clinically relevant and simple immune system measure is related to symptom burden in bipolar disorder.
- Published in:
- Acta Neuropsychiatrica, 2018, v. 30, n. 5, p. 297, doi. 10.1017/neu.2017.34
- By:
- Publication type:
- Article
4
Multiple possible inaccuracies cast doubt on a recent report suggesting selective serotonin reuptake inhibitors to be toxic and ineffective.
- Published in:
- Acta Neuropsychiatrica, 2018, v. 30, n. 5, p. 244, doi. 10.1017/neu.2017.23
- By:
- Publication type:
- Article
5
Do not blame the SSRIs: blame the Hamilton Depression Rating Scale.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
6
Gut–brain actions underlying comorbid anxiety and depression associated with inflammatory bowel disease.
- Published in:
- Acta Neuropsychiatrica, 2018, v. 30, n. 5, p. 275, doi. 10.1017/neu.2017.3
- By:
- Publication type:
- Article